ARK Invest adjusted holdings across several of its exchange-traded funds on Sept. 10, 2026, according to data tracked by Ark Invest Tracker. On the buy side, ARKK and ARKG both added shares of Intellia Therapeutics (NTLA), with combined purchases totaling 89,284 shares. The positions accounted for 0.0149% and 0.0041% of each fund’s total weighting, respectively. ARKW and ARKF also bought shares of the 3IQ Solana Staking ETF (SOLQ.U), purchasing a combined 4,021 shares. Those additions represented 0.001% and 0.0019% of the two funds’ total holdings. On the sell side, ARKK, ARKW and ARKF reduced exposure to Brera Holdings PLC (SLMT), selling a combined 4,156 shares. The position cuts each represented no more than 0.0003% of fund weight. The moves were reported by ChainCatcher, citing monitoring data from Ark Invest Tracker.

ARKK ETF invested nearly $42 million on April 28 across four stocks, including $14.1M in Alphabet and $14.8M in Coreweave, signaling Cathie Wood's strong conviction in AI despite risks from data center delays and Google's search quality issues.

Cathie Wood's ARKK ETF disclosed nearly $42 million in new investments, with $14.8 million in Coreweave and $14.1 million in Google, signaling her continued bet on AI despite risks.

Cathie Wood's ARK Innovation ETF disclosed ~$42M purchases on April 28, with $14.8M in Coreweave and $14.1M in Alphabet, betting on AI growth. The fund also added Intellia Therapeutics and Kratos Defense.

Cathie Wood's ARKK invested $42M in Alphabet, Coreweave, Intellia Therapeutics, and Kratos Defense. $14.8M bet on Coreweave and $14.1M on Google signals strong AI conviction despite risks.